Examining the actions of drug companies in raising prescription drug prices :  hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019. 

 - 1 online resource (iii, 57 pages) 
<br/><br/> "Serial no. 116-01."  CRDP Program record. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Prescription pricing--Government policy--United States.<br/>Pharmaceutical industry--Government policy--United States.<br/>Drugs--Cost control.--United States<br/>Drugs--Prices--Health aspects--United States.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Legislative hearings.
<br/><br/><label>LC Class. No.: </label>KF27  / .O96 2019a 
<br/><br/><label>GPO Item No.: </label>1016-C (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.OV 2:116-01 
<br/><br/><label>Report. No.: </label>Serial no. 116-01 (United States. Congress. House. Committee on Oversight and Reform)